S. Moreno

Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review

P. Thuresson, N. Paracha, K. MacGilchrist, 2016, Expert review of pharmacoeconomics & outcomes research.

Chemoresistance can limit the success of radical surgery followed by early postoperative intraperitoneal chemotherapy in gastric carcinoma (reply)

P. Sugarbaker, S. Moreno, 2000, Revista de Oncología.

C o m p r e h e n s i v e management of resectable gastric cancer: requirement for optimal clearance, containment and perioperative intraperitoneal c h e m o t h e r a p y

P. Sugarbaker, S. Moreno, S. G. Moreno, 2000 .

[Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia].

J. Oliva, R. Alonso, P. Mata, 2009, Revista espanola de cardiologia.

Contraindication to laparoscopic appendectomy

B. Shmookler, P. Sugarbaker, S. Moreno, 1998 .

Letter by moreno regarding article, "cost-effectiveness analysis of continuous flow left ventricular assist devices as destination therapy".

S. Moreno, 2012, Circulation. Heart failure.

Guidelines for diagnosis, staging and treatment of metastatic colorectal cancer by Grupo Español Multidisciplinar en Cancer Digestivo (GEMCAD)

L. Cerezo, E. Espin, J. Aparicio, 2015 .

Comprehensive management of resectable gastric cancer: requirement for optimal clearance, containment and perioperative intraperitoneal chemotherapy

P. Sugarbaker, S. Moreno, S. G. Moreno, 2000, Revista de Oncología.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening

Y. Eishi, E. Quintero, M. Hernández‐Guerra, 2010, Journal of Gastroenterology.